Treatment-related toxicity and improved outcomes with immune checkpoint inhibitors in patients with hepatocellular carcinoma.

Alessio Cortellini,Thomas U. Marron,Pallavi Shruti Mishra-Kalyani,Yutao Gong,Anwaar Saeed,Tomi Jun,Sirish Dharmapuri,Abdul Rafeh Naqash,Uqba Khan,Ahmed Kaseb,Yi-Hsiang Huang,Celina Ang,Julie A. Schneider,Anjana Pillai,Lorenza Rimassa,Richard Pazdur,Marc R. Theoret,Steven Lemery,Lorraine Cheryl Pelosof,David J. Pinato

Treatment-related toxicity and improved outcomes with immune checkpoint inhibitors in patients with hepatocellular carcinoma.

2021

4085Background: The development of treatment-related adverse events (trAE) correlates favorably with clinical outcomes in multiple studies of patients receiving immune checkpoint inhibitors (ICI), ...

Keywords:

Medicine
Internal medicine
Adverse effect
Hepatocellular carcinoma
Oncology
in patient
treatment related toxicity
immune checkpoint inhibitors

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations